Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength.
In mucosal tissues, epithelial M cells capture and transport microbes across the barrier to underlying immune cells. Previous studies suggested that high affinity ligands targeting M cells may be used to deliver mucosal vaccines; here, we show that particle composition and dispersion buffer ionic strength can independently influence their uptake in vivo. First, addition of a poloxamer 188 to nanoparticle formulations increased uptake of intranasally administered nanoparticles in vivo, but the effect was dependent on the presence of the M cell-targeting ligand. Second, solvent ionic strength is known to effect electrostatic interactions; accordingly, reduced ionic strength increased the electrostatic potential between the epithelium and the particles. Interestingly, below a critical ionic strength, intranasal particle uptake in vivo significantly was increased even when controlled for osmolarity. Similar results were obtained for uptake of bacterial particles. Surprisingly, at low ionic strength, the specific enhancement effect by the targeting peptide was negligible. Modeling of the electrostatic forces predicted that the enhancing effects of the M cell-targeting ligand only are enabled at high ionic strength, as particle electrostatic forces are reduced through Debye screening. Thus, electrostatic forces can have a dramatic effect on the in vivo M cell particle uptake independent of the action of targeting ligands. Examination of these forces will be helpful to optimizing mucosal vaccine and drug delivery.
Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA.
Thejani E
TE
Rajapaksa
Kaila M
KM
Bennett
Mary
M
Hamer
Christian
C
Lytle
Victor G J
VG
Rodgers
David D
DD
Lo
D000281:Administration, Intranasal; D000818:Animals; D001419:Bacteria / Q000378:metabolism; D002021:Buffers; D004847:Epithelial Cells / Q000187:drug effects* / Q000378:metabolism; D007477:Ions; D019344:Lactic Acid / Q000737:chemistry; D008024:Ligands; D051379:Mice; D008855:Microscopy, Electron, Scanning / Q000379:methods; D009092:Mucous Membrane / Q000378:metabolism; D053758:Nanoparticles / Q000737:chemistry*; D036103:Nanotechnology / Q000379:methods; D020442:Poloxamer / Q000737:chemistry*; D011100:Polyglycolic Acid / Q000737:chemistry; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D055672:Static Electricity
D002021:Buffers; D007477:Ions; D008024:Ligands; D020442:Poloxamer; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid